Laurus Labs gets USFDA nod for Unit-4

Our Bureau Hyderabad | Updated on July 12, 2019

Laurus Labs has `successfully’ completed the maiden US Food and Drug Administration (USFDA) audit for its Unit-4 without any observations and no form 483 was issued.

The inspection was carried out from July 8-12 this year , the Hyderabad-based company said in a release here on Friday.

The Unit-4 of Laurus Labs, located at Achutapuram SEZ, Visakhapatnam, is meant for manufacturing of Active Pharma Ingredients.

Published on July 12, 2019

Follow us on Telegram, Facebook, Twitter, Instagram, YouTube and Linkedin. You can also download our Android App or IOS App.

This article is closed for comments.
Please Email the Editor